Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | POLR2B | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Polr2b (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POLR2B mRNA | CTD | PMID:22206623 | POLR2B | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Polr2b (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLR2B mRNA | CTD | PMID:17942748 | POLR2B | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of POLR2B mRNA | CTD | PMID:16514628 | POLR2B | Human | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Polr2b (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | POLR2B | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Polr2b (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLR2B mRNA | CTD | PMID:17942748 | POLR2B | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Polr2b (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of POLR2B mRNA | CTD | PMID:33387578 | POLR2B | Human | 2,4,6-tribromophenol | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31675489 | POLR2B | Human | 2,6-dinitrotoluene | affects expression | ISO | Polr2b (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of POLR2B mRNA | CTD | PMID:21346803 | POLR2B | Human | 2-bromohexadecanoic acid | multiple interactions | EXP | | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of POLR2B protein] | CTD | PMID:38195004 | POLR2B | Human | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Polr2b (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:19467301 | POLR2B | Human | afimoxifene | decreases expression | EXP | | 6480464 | afimoxifene results in decreased expression of POLR2B mRNA | CTD | PMID:16514628 | POLR2B | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of POLR2B mRNA | CTD | PMID:33212167 | POLR2B | Human | arsenite(3-) | decreases expression | ISO | Polr2b (Mus musculus) | 6480464 | arsenite results in decreased expression of POLR2B protein | CTD | PMID:37955338 | POLR2B | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of POLR2B mRNA | CTD | PMID:22378314 | POLR2B | Human | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of POLR2B mRNA | CTD | PMID:19162166 | POLR2B | Human | Benzo[ghi]perylene | increases expression | EXP | | 6480464 | 1 and 12-benzoperylene results in increased expression of POLR2B mRNA | CTD | PMID:35182551 | POLR2B | Human | bisphenol A | increases expression | ISO | Polr2b (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of POLR2B mRNA | CTD | PMID:25181051 | POLR2B | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of POLR2B protein | CTD | PMID:37567409 | POLR2B | Human | bisphenol A | decreases expression | ISO | Polr2b (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of POLR2B mRNA | CTD | PMID:30816183 and PMID:34947998 | POLR2B | Human | bisphenol F | increases expression | ISO | Polr2b (Mus musculus) | 6480464 | bisphenol F results in increased expression of POLR2B mRNA | CTD | PMID:38685157 | POLR2B | Human | buspirone | decreases expression | ISO | Polr2b (Rattus norvegicus) | 6480464 | Buspirone results in decreased expression of POLR2B mRNA | CTD | PMID:24136188 | POLR2B | Human | cadmium atom | multiple interactions | EXP | | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of POLR2B protein] and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of POLR2B protein | CTD | PMID:38195004 | POLR2B | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of POLR2B protein] and [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of POLR2B protein | CTD | PMID:38195004 | POLR2B | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of POLR2B mRNA | CTD | PMID:38568856 | POLR2B | Human | crocidolite asbestos | decreases expression | ISO | Polr2b (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of POLR2B mRNA | CTD | PMID:29279043 | POLR2B | Human | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of POLR2B protein | CTD | PMID:31675489 | POLR2B | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of POLR2B mRNA | CTD | PMID:28302478 | POLR2B | Human | epoxiconazole | decreases expression | ISO | Polr2b (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of POLR2B mRNA | CTD | PMID:35436446 | POLR2B | Human | flutamide | increases expression | ISO | Polr2b (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of POLR2B mRNA | CTD | PMID:24136188 | POLR2B | Human | folic acid | multiple interactions | ISO | Polr2b (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POLR2B mRNA | CTD | PMID:22206623 | POLR2B | Human | fulvestrant | decreases expression | EXP | | 6480464 | fulvestrant results in decreased expression of POLR2B mRNA | CTD | PMID:16514628 | POLR2B | Human | geldanamycin | decreases expression | EXP | | 6480464 | geldanamycin results in decreased expression of POLR2B mRNA | CTD | PMID:30166341 | POLR2B | Human | gentamycin | increases expression | ISO | Polr2b (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of POLR2B mRNA | CTD | PMID:22061828 | POLR2B | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of POLR2B protein | CTD | PMID:32959892 | POLR2B | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of POLR2B mRNA | CTD | PMID:28988120 | POLR2B | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Polr2b (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of POLR2B protein | CTD | PMID:26558463 | POLR2B | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of POLR2B mRNA | CTD | PMID:23195993 | POLR2B | Human | oxaliplatin | multiple interactions | ISO | Polr2b (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of POLR2B mRNA | CTD | PMID:25729387 | POLR2B | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of POLR2B mRNA | CTD | PMID:35430440 | POLR2B | Human | paracetamol | affects expression | ISO | Polr2b (Mus musculus) | 6480464 | Acetaminophen affects the expression of POLR2B mRNA | CTD | PMID:17562736 | POLR2B | Human | raloxifene | decreases expression | EXP | | 6480464 | Raloxifene Hydrochloride results in decreased expression of POLR2B mRNA | CTD | PMID:16514628 | POLR2B | Human | resveratrol | decreases expression | ISO | Polr2b (Mus musculus) | 6480464 | resveratrol results in decreased expression of POLR2B protein | CTD | PMID:25505154 | POLR2B | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of POLR2B mRNA | CTD | PMID:23557933 | POLR2B | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of POLR2B protein | CTD | PMID:37664457 | POLR2B | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of POLR2B mRNA | CTD | PMID:33359661 | POLR2B | Human | titanium dioxide | decreases methylation | ISO | Polr2b (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of POLR2B gene and titanium dioxide results in decreased methylation of POLR2B promoter alternative form | CTD | PMID:35295148 | POLR2B | Human | topotecan | multiple interactions | ISO | Polr2b (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of POLR2B mRNA | CTD | PMID:25729387 | POLR2B | Human | trichloroethene | decreases expression | ISO | Polr2b (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of POLR2B mRNA | CTD | PMID:33387578 | POLR2B | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of POLR2B mRNA | CTD | PMID:37042841 | POLR2B | Human | valproic acid | affects expression | ISO | Polr2b (Mus musculus) | 6480464 | Valproic Acid affects the expression of POLR2B mRNA | CTD | PMID:17292431 | |